Reduction of lymphotoxin beta receptor induces cellular senescence via the MDMX-p53 pathway

Abstract

The lymphotoxin beta receptor (LT beta R), a key activator of non-canonical NF-kappa B signaling, is expressed in various cells, including cancer cells. Although high expression of LT beta R has been associated with poor patient prognosis and drug resistance, conflicting evidence suggested that LT beta R induces apoptosis. To investigate the functional role of LT beta R in tumors, we performed LT beta R knockdown in cancer cells. We found that LT beta R knockdown induced senescence phenomena such as reduced cell number; increased cell size; increased SA-beta-Gal activity; and upregulated p53, MDM2 and p21 expression. Moreover, LT beta R knockdown induced p21-mediated senescence in p53 WT cancer cells, but not in p53 mutant cancer cells. The level of p53 is regulated by MDM2 and MDMX; MDMX enhances MDM2 activity but is also subject to MDM2-mediated degradation in the nucleus. We found that the intracellular domain of LT beta R bound to MDMX thereby inhibited its nuclear translocation, which in turn reduced MDMX ubiquitination and consequently promoted p53 ubiquitination. Additionally, tumors derived from B16F10LT beta R-KO cells in WT mice exhibited significantly reduced growth compared to those derived from B16F10WT cells. These results demonstrate that LT beta R regulates p53 protein levels by modulating MDMX stability and localization, resulting in p53-mediated cellular senescence.LT beta R regulates p53-mediated senescence by inhibiting MDMX nuclear translocation and degradation. LT beta R interacts with MDMX in the cytoplasm, preventing its nuclear translocation and degradation under normal conditions (dotted arrows). When LT beta R is depleted, MDMX is translocated into the nucleus by MDM2, and undergoes degradation (solid arrows). This reduces p53 degradation and consequently activates p53, leading to p21 transcription and the induction of cellular senescence. Treatment with doxorubicin (Dox) or nutlin-3a further enhances p53-mediated transcriptional activation of p21, and their combination with LT beta R depletion exerts an additive effect in promoting cellular senescence.